Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

21
2
NYSE:EW (USA)   Ordinary Shares
$ 86.43 -1.58 (-1.8%) 10:08 PM EST
37.58
P/B:
7.81
Market Cap:
$ 52.02B
Enterprise V:
$ 52.03B
Volume:
4.96M
Avg Vol (2M):
3.65M
Also Trade In:
Volume:
4.96M
Avg Vol (2M):
3.65M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Edwards Lifesciences Corp ( ) from 2000 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Edwards Lifesciences stock (EW) PE ratio as of Apr 27 2024 is 37.58. More Details

Edwards Lifesciences Corp (EW) PE Ratio (TTM) Chart

To

Edwards Lifesciences Corp (EW) PE Ratio (TTM) Historical Data

Total 1217
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Edwards Lifesciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-27 37.6 2024-02-23 38.1
2024-04-26 37.6 2024-02-22 38.1
2024-04-25 38.3 2024-02-21 37.7
2024-04-24 38.5 2024-02-20 37.8
2024-04-23 38.1 2024-02-16 37.4
2024-04-22 37.8 2024-02-15 37.4
2024-04-19 37.4 2024-02-14 37.4
2024-04-18 37.6 2024-02-13 37.5
2024-04-17 37.9 2024-02-12 37.9
2024-04-16 39.1 2024-02-09 37.0
2024-04-15 38.8 2024-02-08 37.3
2024-04-12 39.3 2024-02-07 37.7
2024-04-11 39.7 2024-02-06 38.4
2024-04-10 39.8 2024-02-05 37.4
2024-04-09 40.5 2024-02-02 37.4
2024-04-08 40.1 2024-02-01 34.2
2024-04-05 40.3 2024-01-31 34.1
2024-04-04 39.6 2024-01-30 32.1
2024-04-03 40.4 2024-01-29 32.4
2024-04-02 41.0 2024-01-26 31.8
2024-04-01 41.0 2024-01-25 32.0
2024-03-28 41.5 2024-01-24 31.5
2024-03-27 41.4 2024-01-23 32.5
2024-03-26 40.6 2024-01-22 32.7
2024-03-25 40.5 2024-01-19 32.3
2024-03-22 40.8 2024-01-18 32.4
2024-03-21 41.2 2024-01-17 32.1
2024-03-20 40.5 2024-01-16 32.2
2024-03-19 41.0 2024-01-12 32.2
2024-03-18 40.4 2024-01-11 32.7
2024-03-15 40.1 2024-01-10 33.1
2024-03-14 40.6 2024-01-09 33.0
2024-03-13 40.4 2024-01-08 32.9
2024-03-12 39.5 2024-01-05 31.7
2024-03-11 39.5 2024-01-04 32.0
2024-03-08 40.1 2024-01-03 31.8
2024-03-07 40.8 2024-01-02 32.9
2024-03-06 38.4 2023-12-29 33.1
2024-03-05 37.4 2023-12-28 33.4
2024-03-04 37.8 2023-12-27 32.6
2024-03-01 37.0 2023-12-26 32.6
2024-02-29 36.9 2023-12-22 32.4
2024-02-28 37.4 2023-12-21 32.0
2024-02-27 37.6 2023-12-20 31.7
2024-02-26 37.5 2023-12-19 32.2

Edwards Lifesciences Corp (EW) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Edwards Lifesciences Corp logo
Edwards Lifesciences Corp
NAICS : 339113 SIC : 3842
ISIN : US28176E1082

Share Class Description:

EW: Ordinary Shares
Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.